JFS WEALTH ADVISORS, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
JFS WEALTH ADVISORS, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$3,494
+2.6%
39
-2.5%
0.00%
Q2 2023$3,406
+2.9%
400.0%0.00%
Q1 2023$3,310
-14.1%
40
-18.4%
0.00%
Q4 2022$3,854
+28.5%
49
+4.3%
0.00%
Q3 2022$3,0000.0%47
-4.1%
0.00%
Q2 2022$3,000
+50.0%
49
+88.5%
0.00%
Q1 2022$2,000
+100.0%
26
+116.7%
0.00%
Q4 2021$1,000120.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders